Universe Pharmaceuticals (UPC) Cash & Equivalents: 2019-2024
Historic Cash & Equivalents for Universe Pharmaceuticals (UPC) over the last 6 years, with Sep 2024 value amounting to $29.5 million.
- Universe Pharmaceuticals' Cash & Equivalents rose 458.11% to $29.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $29.5 million, marking a year-over-year increase of 458.11%. This contributed to the annual value of $29.5 million for FY2024, which is 458.11% up from last year.
- Latest data reveals that Universe Pharmaceuticals reported Cash & Equivalents of $29.5 million as of FY2024, which was up 458.11% from $5.3 million recorded in FY2023.
- In the past 5 years, Universe Pharmaceuticals' Cash & Equivalents registered a high of $29.5 million during FY2024, and its lowest value of $5.3 million during FY2023.
- In the last 3 years, Universe Pharmaceuticals' Cash & Equivalents had a median value of $5.7 million in 2022 and averaged $13.5 million.
- As far as peak fluctuations go, Universe Pharmaceuticals' Cash & Equivalents dropped by 29.30% in 2022, and later skyrocketed by 458.11% in 2024.
- Yearly analysis of 5 years shows Universe Pharmaceuticals' Cash & Equivalents stood at $10.1 million in 2020, then declined by 19.69% to $8.1 million in 2021, then fell by 29.30% to $5.7 million in 2022, then decreased by 7.46% to $5.3 million in 2023, then skyrocketed by 458.11% to $29.5 million in 2024.